Ubs Oconnor LLC Nuvasive Inc Transaction History

Ubs Oconnor LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Feb 14, 2024	BUY	$36.71 - $44.15 $30.9 Million - $37.2 Million	841,845 Added 841.85%	941,845 $39.2 Billion
Q1 2023 Feb 14, 2024	BUY	$36.81 - $48.12 $3.68 Million - $4.81 Million	100,000 New	100,000 $4.13 Billion
Q2 2022 Aug 12, 2022	BUY	$46.84 - $59.75 $862,183 - $1.1 Million	18,407 Added 68.17%	45,407 $2.23 Million
Q1 2022 May 16, 2022	BUY	$48.09 - $57.79 $1.3 Million - $1.56 Million	27,000 New	27,000 $1.53 Million

116K

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

Stay updated on Ubs Oconnor LLC with notifications on news.